PATENT CLAIM ANALYSIS

Application Number: 16009979
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["544", "361000"]

Abstract:
The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.

Claim (Index 8):
A method for modulating pathological Tau metabolism, in a patient in need of such treatment, which comprises administering to said patient an effective amount of a compound of Formula I or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 94.0
- Lexical Diversity: 1.03448
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15558921', '14740595', '14486040', '15503636', '14271177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7625261378900324
- 35 USC 102 Novelty (BERT): 0.5668938178369962
- Combined Prediction Score: 0.7429629058847288
- Mean Citation Score: 326.28577399999995
- Max Citation Score: 467.90796
- Similarity Product: 337.7172374915528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test